Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2012
06/28/2012WO2012087234A1 A composition comprising at least to compounds which induces indolamine 2,3-dioxygenase (ido), for the treatment of an autoimmune disorder or suffering from immune rejection of organs
06/28/2012WO2012087229A1 2-carboxamide-4-piperazinyl-benzofuran derivative
06/28/2012WO2012087181A1 Pharmaceutical composition for treating viral diseases
06/28/2012WO2012087115A1 Cancer targeting using carbonic anhydrase isoform ix inhibitors
06/28/2012WO2012087094A1 Inhalable pharmaceutical composition for treating asthma by airborne administration by means of an emulation aerosol suction unit
06/28/2012WO2012087047A2 Percutaneous absorption preparation containing rivastigmine
06/28/2012WO2012087040A2 Conjugate for photodynamic diagnosis or therapy and method for preparing same
06/28/2012WO2012086964A2 Amphiphilic cyclic phosphazene trimer, hydrophobic pharmaceutical formulation micellized by amphiphilic cyclic phosphazene trimer, and preparation methods thereof
06/28/2012WO2012086889A1 Novel hispidin-based compound having an enoyl-reductase-inhibiting and an antimicrobial activity
06/28/2012WO2012086857A1 Combination body for photodynamic diagnosis or therapy and a production method therefor
06/28/2012WO2012086812A1 Glycoside compound
06/28/2012WO2012086811A1 Food intake suppressant and anti-obesity agent
06/28/2012WO2012086809A1 Accurate and highly sensitive method for measuring activity of human fgf19 and agent for regulating activity of human fgf19
06/28/2012WO2012086735A1 Condensed heterocyclic compound
06/28/2012WO2012086727A1 Novel substituted isoquinoline derivative
06/28/2012WO2012086712A1 Elution-controlled oral liquid preparation
06/28/2012WO2012086683A1 Metal-salen complex compound and production method for same
06/28/2012WO2012086462A1 Isoxazoline compound and pest control agent
06/28/2012WO2012086406A1 Glp-1 secretagogue
06/28/2012WO2012086241A1 Optically-active diazabicyclooctane derivative and method for manufacturing same
06/28/2012WO2012086184A1 Diphenyl sulfide derivative and pharmaceutical product which contains same as active ingredient
06/28/2012WO2012086157A1 Method of intensifying the physiological action of caffeine
06/28/2012WO2012086114A1 Macrolide compound having anticancer effect
06/28/2012WO2012085954A1 Combination comprising d-apartic acid and l-arginine or salts thereof for the improvement of cognitive activities and memory in dementia such as dementia senile and alzheimer's disease
06/28/2012WO2012085927A2 Tadalafil compositions
06/28/2012WO2012085857A1 3,8-diaza-bicyclo[4.2.0]oct-3-yl amides
06/28/2012WO2012085852A1 3,8-diaza-bicyclo[4.2.0]oct-8-yl amides
06/28/2012WO2012085815A1 Bi-heteroaryl compounds as vps34 inhibitors
06/28/2012WO2012085785A1 Combination and composition for treating obesity
06/28/2012WO2012085745A1 Glucagon receptor modulators
06/28/2012WO2012085721A1 Novel fused pyridine compounds as casein kinase inhibitors
06/28/2012WO2012085683A1 The use of spinosyns and spinosyn compositions as local anesthetics and as antiarrhythmic agents
06/28/2012WO2012085662A1 2-amino-4-arylthiazole compounds as trpa1 antagonists
06/28/2012WO2012085657A2 Tamper resistant solid oral dosage forms
06/28/2012WO2012085654A1 Novel anti-tuberculosis agents
06/28/2012WO2012085650A1 Substituted pyridines as sodium channel blockers
06/28/2012WO2012085648A1 Phosphorus-substituted quinoxaline-type piperidine compounds and uses thereof
06/28/2012WO2012085645A1 Polymorphs of 3-chloro-4[(2r)-2
06/28/2012WO2012085608A2 Use of trifluoro phthalimides for the treatment of cancerous diseases
06/28/2012WO2012085603A2 Dna sensors
06/28/2012WO2012085586A1 Mexiletine prodrugs
06/28/2012WO2012085583A1 New compound
06/28/2012WO2012085582A1 Compound
06/28/2012WO2012085559A1 Antibacterial or anti-acne formulations containing usnic acid or an usnate and a metal salt
06/28/2012WO2012085553A1 Sanglifehrin derivatives and methods for their production
06/28/2012WO2012085501A1 8 - sulfo - imidazotetrazin- 4 - one compounds and their use as anticancer drug
06/28/2012WO2012085483A1 Dermatological foams obtained from a gel or suspension containing benzoyl peroxide
06/28/2012WO2012085481A1 Dermatological foams obtained from a gel or suspension containing adapalene
06/28/2012WO2012085480A1 Dermatological foams obtained from a gel or suspension containing a combination of adapalene and benzoyl peroxide
06/28/2012WO2012085475A1 Novel platinum-carbene complexes and use thereof as medicaments
06/28/2012WO2012085321A1 Use of l-carnitine and compositions thereof for treating and preventing renal damage
06/28/2012WO2012085304A1 Phosphomycin pharmaceutical composition
06/28/2012WO2012085244A1 Pyrimidinone derivatives, preparation thereof and pharmaceutical use thereof
06/28/2012WO2012085222A1 Novel phenazine derivatives and their use
06/28/2012WO2012085197A1 Pharmaceutical composites of poorly water soluble drugs and polymers
06/28/2012WO2012085189A1 Ingenol-3-acylates i
06/28/2012WO2012085185A1 Aqueous solution of ambroxol
06/28/2012WO2012085176A1 Tricyclic pyrazinone compounds, compositions and methods of use thereof as janus kinase inhibitors
06/28/2012WO2012085171A2 Pharmaceutical compositions of pyridinium and quinolinium derivatives
06/28/2012WO2012085167A1 Metabotropic glutamate receptor modulators
06/28/2012WO2012085166A1 Metabotropic glutamate receptor modulators
06/28/2012WO2012085160A1 Formulations of antiparasitic agents for topical administration to swine
06/28/2012WO2012085139A1 Otic composition for companion animals
06/28/2012WO2012085133A1 Synthesis of intermediates for preparing anacetrapib and derivatives thereof
06/28/2012WO2012085127A1 New triazolylphenyl sulfonamides as serine/threonine kinase inhibitors
06/28/2012WO2012085126A1 Oxindolopyrimidine as igf1r receptor inhibitors
06/28/2012WO2012085092A1 Antibacterial and antifungal substances biphenylyl compounds
06/28/2012WO2012085071A1 Process for the preparation of a pharmaceutical composition comprising a low soluble pharmaceutically active ingredient
06/28/2012WO2012085068A1 Kit-in-parts for cleaning and treating ears of companion animals
06/28/2012WO2012085038A1 5,6-DIHYDRO-IMIDAZO[1,2-a]PYRAZIN-8-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE)
06/28/2012WO2012085003A1 2-hydroxyisoquinoline-1,3(2h,4h)-diones and related compounds useful as hiv replication inhibitors
06/28/2012WO2012085001A1 Diarylpyridazinone derivatives, preparation thereof, and use thereof for the treatment of humans
06/28/2012WO2012084999A1 Prokineticin 1 receptor agonists and their uses
06/28/2012WO2012084978A1 (r)-2-(3-fluoro-4-phenylphenyl)propionic acid for use in the treatment of skin diseases
06/28/2012WO2012084976A1 Novel multicomponent crystals made of ([2-amino-6-(4-fluoro-benzylamino)-pyridin-3-yl]-carbamic acid ethyl ester and an arylpropionic acid
06/28/2012WO2012084975A1 Novel multicomponent crystals made of ([2-amino-6-(4-fluoro-benzylamino)- pyridin-3-yl]-carbamic acid ethyl ester and 2-[2-[(2,6-dichlorphenyl)-amino]-phenyl]-acetic acid
06/28/2012WO2012084971A1 Indole derivatives as agents against gram-negative and gram-positive bacteria
06/28/2012WO2012084969A1 Adhesive composition containing rotigotine and transdermal therapeutic system comprising the adhesive composition
06/28/2012WO2012084928A1 Radioiodinated guanidines
06/28/2012WO2012084873A1 4- (hetero) aryl - ethynyl - octahydro - indole - 1 - carboxylic acid esters
06/28/2012WO2012084870A1 Modulators and methods for the treatment of rosacea
06/28/2012WO2012084857A2 Method for producing 2-(triazinylcarbonyl) sulfonanilides
06/28/2012WO2012084855A2 Method for producing triazinyl-substituted oxindoles
06/28/2012WO2012084804A1 NOVEL ANTIFUNGAL 5,6-DIHYDRO-4H-PYRROLO[1,2-a][1,4]- BENZODIAZEPINES AND 6H-PYRROLO[1,2-a][1,4]BENZODIAZEPINES SUBSTITUTED WITH BICYCLIC BENZENE DERIVATIVES
06/28/2012WO2012084711A1 N-substituted azetidine derivatives
06/28/2012WO2012084709A1 Mirnas in joint disease
06/28/2012WO2012084704A1 Indazolyl triazole derivatives as irak inhibitors
06/28/2012WO2012084683A1 Conjugated 3-(indolyl)- and 3-(azaindolyl)-4-arylmaleimide compounds and their use in tumor treatment
06/28/2012WO2012084602A1 Aryl triazole compounds with antitumoural activity
06/28/2012WO2012084446A1 Compound having antibacterial activity
06/28/2012WO2012084267A1 Derivatives of englerin for the treatment of cancer
06/28/2012WO2012084126A2 Formulation of lacosamide
06/28/2012WO2012083954A1 3-acyl-ingenols ii
06/28/2012WO2012083953A1 Ingenol-3-acylates iii and ingenol-3-carbamates
06/28/2012WO2012083947A1 Chewing gum composition comprising cross-linked polyacrylic acid
06/28/2012WO2012083866A1 Quinoline derivatives as anti-cancer agents
06/28/2012WO2012083801A1 Streoidal anti-progesterone composition, preparation method therefor, and use thereof
06/28/2012WO2012083592A1 Artificial oil body carrier used for targeted breast cancer therapy and preparation method and application of the same
06/28/2012WO2012083571A1 Carotenoid oil suspension with high bioavailability and preparation method thereof
06/28/2012WO2012083548A1 Administration method of citicoline for treating stroke
1 ... 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 ... 7860